Markus Schick

Markus Schick is an innovative leader in the field of oncology, currently serving as the Senior Director and Head of Biomarker Development | Computational Pathology at AstraZeneca. With a focus on integrating AI-driven predictive biomarkers throughout the drug development process, they are committed to advancing precision medicine. Previously, Markus held roles as a Team Lead and Principal Investigator at Charité and as a PhD candidate at Klinikum rechts der Isar, where they concentrated on precision oncology and therapeutic interventions. Their educational background includes ongoing studies towards a Dr. rer. nat. at Technische Universität München and additional qualifications in biology, chemistry, and IT from Universität Regensburg and the University of Michigan.